(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(乙酰氧基)-5,6,21,23-四羟基-27-甲氧基-2,4,11,16,20,22,24,26-八甲基-2,7-(环氧十五烷[1,11,13]三亚氨基)苯并呋喃[4,5-e]吡啶[1,2-a]苯并咪唑-1,15(2H)-二酮

中文名称：(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(乙酰氧基)-5,6,21,23-四羟基-27-甲氧基-2,4,11,16,20,22,24,26-八甲基-2,7-(环氧十五烷[1,11,13]三亚氨基)苯并呋喃[4,5-e]吡啶[1,2-a]苯并咪唑-1,15(2H)-二酮
CAS号：80621-81-4
中文别名：利福西亚胺;西尼地平;利福昔明;利福西明;4-脱氧-4'-甲基吡啶并[1',2'-1,2]咪唑并[5,4-C]利福素;Rifaximin 利福昔明;WAKO181-02041利福昔明标准品;地龙提取物;金刚石,玻璃刀,钻石,菱形;利福昔明 EP标准品;利福昔明 标准品;利福昔明系统适用性 EP标准品;4-脱氧-4'-甲基吡啶并[1',2'-1,2]咪唑并[5,4-C]利福素SV;利福西亚胺,利福昔明;利福西亚胺,西尼地平;利福昔明​;利福昔明系统适用性
英文名称：Rifaximin
英文别名：Rifaximin;2S-Acetyloxy-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11, 16,20,22,24,26-octamethyl-2,7-(epoxypentoeleca(1,11,13)trienimino)benzofuro[4,5-e]pyride[1,2-a]benzimidazole-1,15(2H)-dione;4-DEOXY-4'-METHYLPYRIDO[1',2'-1,2]IMIDAZO[5,4-C]RIFAMYCIN SV;fatroximin;l105;l105sv;normix;RIFACOL;RIFAMIXIN;rifaxidin;XIFAXAN;BDBM50347620;alpha-0817185;Rifaximine;RIFAXIMIN [USAN];RIFAXIMIN [INN];2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-;AB01209738_04;Rifaximin [USAN:INN:BAN];(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,1;RIFAXIMIN (MART.);L 105 (Ansamacrolide antibiotic);Rifaximina [Spanish];NSC-758957;L/105;RIFAXIMIN [MART.];BRN 3584528;L 105;D02554;88747-56-2;RIFAXIMIN [VANDF];Xifaxsan;C43H51N3O11;CHEMBL1617;AKOS015963053;Flonorm;HB2568;DB01220;Rifaximina;RIFAXIMIN (EP IMPURITY);DTXSID7045998;[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate;Rifaximin, Antibiotic for Culture Media Use Only;AB01209738-03;UNII-L36O5T016N;L36O5T016N;DTXCID5025998;RIFAXIMIN [EP MONOGRAPH];RIFAXIMIN [JAN];Spiraxin;AC-19112;Rifaximin 1000 microg/mL in Acetonitrile;Q-201671;Ritacol;s1790;RIFAXIMIN (EP MONOGRAPH);5-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-2;4-deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin;RIFAXIMIN [EP IMPURITY];(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-acetate;NZCRJKRKKOLAOJ-XRCRFVBUSA-N;Rifaximine [French];Rifaximinum;CHEBI:75246;Xifaxan (TN);4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4-c)rifamycin SV;D06AX11;Rifamycin L 105SV;Rifaximin (Xifaxan);Rifaximinum (Latin);Lumenax;rifaximinun;AB01209738-01;GTPL12012;A07AA11;L 105SV;5-yl acetate;CCG-221129;2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)BENZOFURO(4,5-E)PYRIDO(1,2-A)BENZIMIDAZOLE-1,15(2H)-DIONE, 25-(ACETYLOXY)-5,6,21,23-TETRAHYDROXY-27-METHOXY-2,4,11,16,20,22,24,26-OCTAMETHYL-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-;Rifamycin L 105;L-105;RedActiv;Rifaximin (JAN/USAN/INN);80621-81-4;[(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,3...
EINECS:
分子式：C43H51N3O11
分子量：785.88